Shamburg News · 8-K filed Oct 19, 2026, 8:49 AM EDT

IRulya Therapeutics Posts Updated October 2026 Corporate Presentation on Website

IRLA · IRulya Therapeutics Inc.

  • Reg FD disclosure
  • Other event
  • Materiality: low

On October 19, 2026, IRulya Therapeutics Inc. posted its Corporate Presentation, dated October 2026, on its investor website. The presentation is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) and is not deemed filed under Section 18 of the Exchange Act. The presentation describes the company's LAM-001 inhaled rapamycin programs in PH-ILD, BOS and SAPH and their anticipated data readouts.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001193125-26-424731.

Written from the filing by Shamburg Markets. Figures are as reported by the company.